Amgen: Argus Research raises PT to $400 from $360, maintains Buy rating.

viernes, 6 de febrero de 2026, 12:32 pm ET1 min de lectura
AMGN--

Amgen: Argus Research raises PT to $400 from $360, maintains Buy rating.

Amgen: Argus Research raises PT to $400 from $360, maintains Buy rating.

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios